Press release
Nonalcoholic Fatty Liver Disease Market Demand Is Rising With Surging Obesity And Diagnostic Innovation | Pfizer Inc., AstraZeneca, Novartis AG, Takeda Pharmaceutical Company Limited.
Nonalcoholic Fatty Liver Disease Market
Nonalcoholic Fatty Liver Disease Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With a focus on emerging drug technologies, evolving treatment paradigms, and regulatory frameworks, the report delivers strategic insights to support stakeholders in navigating the rapidly advancing sector from 2025 to 2033.
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/nonalcoholic-fatty-liver-disease-market?ophp
NAFLD is a spectrum of liver conditions characterized by fat accumulation in the liver not caused by alcohol. The market is growing rapidly due to rising obesity, diabetes, and metabolic syndrome prevalence. Despite the lack of approved therapies, the pipeline is rich with NASH (a severe form of NAFLD) drugs, making this a key focus area for pharmaceutical innovation.
Nonalcoholic Fatty Liver Disease Market Competitors Overview:
Pfizer Inc., AstraZeneca, Novartis AG, Takeda Pharmaceutical Company Limited., Intercept Pharmaceuticals, Inc., F. Hoffmann-La Roche Ag, Merck & Co., Inc., Abbvie Inc., And Gilead Sciences, Inc. among others.
Important Industry Updates of 2023, 2024 and 2025:
☐ February 2025: Madrigal Pharmaceuticals Announced positive two-year results from the MAESTRO-NAFLD-1 Phase 3 trial, demonstrating significant reduction in liver stiffness with Rezdiffra in patients with compensated NASH cirrhosis (F4c). Ongoing data from the MAESTRO-NASH OUTCOMES trial will follow in 2027
Methodology and Scope
The Nonalcoholic Fatty Liver Disease Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/nonalcoholic-fatty-liver-disease-market?ophp
Nonalcoholic Fatty Liver Disease Market Segments Overview:
☐ By Drug Class (Antioxidants, Lipid-Lowering Drugs, Insulin sensitizers, Pentoxifylline, Angiotensin Receptor Blockers, Others)
☐ By Disease Stage (Non-Alcoholic Steatohepatitis (NASH), Cirrhosis, Fibrosis)
☐ By Route of Administration (Injectable, Oral, Other)
☐ By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others)
Regional Overview for Nonalcoholic Fatty Liver Disease Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=nonalcoholic-fatty-liver-disease-market?ophp
The Report Covers:
➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.
People Also Ask:
➤ What are the current global trends in sales, production, imports, and exports within the «Keyword» market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the «Keyword» market?
Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nonalcoholic Fatty Liver Disease Market Demand Is Rising With Surging Obesity And Diagnostic Innovation | Pfizer Inc., AstraZeneca, Novartis AG, Takeda Pharmaceutical Company Limited. here
News-ID: 4112800 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Bladder Cancer Vaccines Market 2025 | Growth Drivers, Key Players …
Market Size and Growth
The Global Bladder Cancer Vaccines market reached US$254 million in 2024, up from US$209 million in 2023, and is projected to reach US$1,446 million by 2033, growing at a robust CAGR of 21.32% from 2025 to 2033.
Key Development & Recent Mergers and acquisitions:
United States: Recent Industry Developments
✅ In September 2025, the U.S. FDA approved the Gemcitabine intravesical system (InlexzoTM), previously TAR-200, for adult patients with BCG-unresponsive…
United States Peptide Synthesis Market 2025 | Growth Drivers, Key Players & Inve …
Market Size and Growth
The Global Peptide Synthesis market reached US$ 780.00 million in 2023, with a rise to US$ 860.99 million in 2024, and is expected to reach US$ 2,268.16 million by 2033, growing at a CAGR of 11.4% during the forecast period 2025-2033.
Key Development:
United States: Recent Industry Developments
✅ In October 2025, Cambrex announced a US $120 million investment to expand its API and peptide-manufacturing capacity at its Charles…
United States Vaccine Adjuvants Market to hit $1,280.35 million by 2033 - Exclus …
"The global vaccine adjuvants market size reached US$ 703.15 Million in 2024 from US$ 661.09 Million in 2023 and is expected to reach US$ 1,280.35 Million by 2033, growing at a CAGR of 6.9% during the forecast period 2025-2033." As per DataM intelligence research report
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/vaccine-adjuvants-market
United States: Recent Industry Developments
✅ In June 2025, the U.S. vaccine adjuvants market reached around…
United States Sterile Injectables Market to hit $1,072.97 million by 2033 - Excl …
"The Global Sterile Injectables Market reached US$ 542.79 Million with a rise of US$ 578.61 Million in 2024 and is expected to reach US$ 1072.97 Million by 2033, growing at a CAGR of 7.15% during the forecast period 2025-2033." As per DataM intelligence research report
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/sterile-injectable-market?sp
United States: Recent Industry Developments
✅ In September 2025, Pfizer Inc. expanded its sterile injectables manufacturing…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
